Amphiregulin Modifies the Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN Acute Gvhd Therapy Trials

Holtan, Shernan G. and Defor, Todd E. and Howard, Alan and Pidala, Joseph A. and Levine, John E. and Wu, Juan Maggie and Khera, Nandita and Lee, Stephanie J. and Bolanos-Meade, Javier and Ho, Vincent T. and Alousi, Amin M. and Inamoto, Yoshihiro and Chen, George L. and Arora, Mukta and Palmer, Jeanne and Flowers, Mary E. and Cutler, Corey and Renteria, Anne S. and Lukez, Alexander and Arai, Sally and Lazaryan, Aleksandr and Hogan, William J. and Newell, Laura F. and Jagasia, Madan and Wood, William A. and Krupski, M. Christa and Yanik, Gregory A. and Bunworasate, Udomsak and Hexner, Elizabeth O. and Ayuk, Francis and Holler, Ernst and Mayer, Sebastian and Pusic, Iskra and Duong, Hien K. and Efebera, Yvonne A. and Ferrara, James and Blazar, Bruce R. and Mortari, Angela and Weisdorf, Daniel J. and MacMillan, Margaret L. (2018) Amphiregulin Modifies the Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN Acute Gvhd Therapy Trials. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24 (3supp1): ‏ 231. S177-S178. ISSN 1083-8791, 1523-6536

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 26 Jun 2020 10:27
Last Modified: 26 Jun 2020 10:27
URI: https://pred.uni-regensburg.de/id/eprint/14995

Actions (login required)

View Item View Item